ZTS
Zoetis Inc. Class A
Company Overview
| Mkt Cap | $64.68B | Price | $144.52 |
| Volume | 2.27M | Change | +0.30% |
| P/E Ratio | 26.0 | Open | $143.37 |
| Revenue | $9.3B | Prev Close | $144.09 |
| Net Income | $2.5B | 52W Range | $139.34 - $181.85 |
| Div Yield | 2.00% | Target | $191.29 |
| Overall | 59 | Value | 75 |
| Quality | 57 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyZoetis Inc. Class A (ZTS) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $144.52 with a market capitalization of $64.68 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating average quality indicators with a MarketXLS quality score of 57.
Today's trading session shows ZTS with a volume of 2.27 million shares. The stock opened down 0.50% from yesterday's close of $144.09. Current analyst estimates project earnings of $6.35 per share for this year, with next year targeting $6.87.
ZTS demonstrates weak technical indicators based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including LLY, MRK, PFE, PAHC, ICCC.
Key investment considerations for ZTS include average overall investment profile. The company offers a dividend yield of 2% and analyst price targets suggest potential upside of 32.4%. The stock shows reasonable valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 09:11 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZTS | $144.52 | +0.3% | 2.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |